dChan - Q Origins Project Archive

>>14122711 (pb- notable) Wanted: Information about corporate registration ofInbrainNeuroelectronics headquarted in Barcelona, Spain

>>14024600 (pb)

https://interhospi.com/graphene-nanotech-neural-implant-company-inbrain-neuroelectronics-receives-e14-35-million-investment/

Graphene nanotech neural implant company inbrain Neuroelectronics receives 14.35 million investment

,30 March 2021

inbrain Neuroelectronics, a spin-off Graphene Flagship partners the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and ICREA, Spain, has received a ?14.35 million Series A investment, one of the biggest rounds in the Spanish MedTech industry. The investment will allow inbrain to bring their novel neurotechnology to humans for the first time.

inbrain Neuroelectronics was established in 2019, at the intersection between MedTech, DeepTech and Digital Health, with a mission to decode brain signals to develop medical solutions for patients with epilepsy, Parkinson's disease and other neurological disorders. The company designs small implantable brain intelligent systems - built around an innovative nanoscale graphene electrode - with the ability to interpret brain signals with unprecedented high fidelity, producing a therapeutic response adapted to the clinical condition of each patient.

Disruptive technology based on graphene

Existing brain interfaces are based on metals such as platinum and iridium, which impose significant restrictions in terms of miniaturisation and signal resolution, and therefore cause considerable side effects. For this reason, there is a 50% rejection rate in candidate patients. inbrain Neuroelectronics uses a disruptive technology based on graphene which will overcome the current limitations of metal-based neural interfaces.

According to a 2010 study commissioned by the European Brain Council, the cost of brain disorders in Europe alone is approximately ?800 billion per year, with more than one-third of the population affected. Around 30% of patients with a neuronal disease are resistant to pharmacological treatment and do not have an effective therapy. The high incidence of brain-related diseases worldwide, and their huge social cost, call for greater investments in basic research in this field, with the aim of developing new and more efficient therapeutic and diagnostic tools.

In June last year, inbrain received a first-seed investment from a syndicate of investors led by Asabys Partners (through Sabadell-Asabys Health Innovation Investment) and Alta Life Sciences, including the Institut Catal� de Finances (ICF), Finaves (IESE Business School) and BStartUp. The most recent investment was co-led by Asabys Partners and Alta Life Sciences, and joined by Vsquared Ventures, a DeepTech-focused early-stage venture capitalist based in Munich; TruVenturo GmbH, Germany's most successful tech and life science company builders; and CDTI, at the Spanish Ministry of Science and Innovation.

Cinzia Spinato, Graphene Flagship Business Developer for Biomedical Applications, said: "inbrain is leading the way in the field of graphene-based implantable brain devices, and I hope that this success will raise the interest of new stakeholders and corporates towards the opportunities graphene offers in the healthcare domain. I remember when inbrain was born, and it is impressive how they have grown so fast: transforming a laboratory technology into a product - an outstanding milestone. This investment will be fundamental to speed up the development of graphene-based medical devices, which will be tested on patients much earlier than everyone expected."

Technological transformation

inbrain Neuroelectronics is bringing a complete technological transformation to the treatment of neurological diseases. Its brain implantable intelligent systems are based on graphene electrodes, which allow miniaturisation to nanoscale fabrication, with the potential to reach single-neuron resolution. The extraordinary properties of graphene - which is light, biocompatible, flexible and extremely conductive - are harnessed in much smaller devices that are safer to implant and can be programmed, upgraded and recharged wirelessly.

Driven by artificial intelligence, the implant can learn from the brain of each patient and trigger adaptive responses to deliver personalised neurological therapy. In addition, the use of big data management will permit remote monitoring of the device and data processing.

The technology has already been validated in in vitro and in vivo, and biocompatibility and toxicity tests have been successful. Studies on large animals have been completed and the investment will bring the technology to human patients, in collaboration with key neurosurgical and neurological groups in Europe.

>>14123329

“This substantial investment exemplifies the growing interest and ever-expanding opportunities to exploit graphene and layered materials in the biomedical domain. Due to its unique properties, graphene has the potential to transform this application area. The Graphene Flagship has chosen biomedical applications as a focus area for commercialisation, and continues to support efforts to foster new innovations – from research to the factory floor, now and into future.”

— Kari Hjelt, Graphene Flagship Head of Innovation

The Graphene Flagship, Funded by the European Commission, aims to secure a major role for Europe in the ongoing technological revolution, helping to bring graphene innovation out of the lab and into commercial applications."

"the internet of bodies

https://www.weforum.org/agenda/2020/06/internet-of-bodies-covid19-recovery-governance-health-data/

We’re entering the era of the “Internet of Bodies”: collecting our physical data via a range of devices that can be implanted, swallowed or worn.

The result is a huge amount of health-related data that could improve human wellbeing around the world, and prove crucial in fighting the COVID-19 pandemic.

" Asthe Internet of Bodiesspreads into every aspect of our existence, we are facing a range of new challenges. ""

"In recent years, researchers have been building artificial neurons and synapses with some success but without the flexibility needed for learning. However, this first-of-its-kind synthetic synapse mimics the plasticity of the brain, bringing science one step closer to human-like artificial intelligence."

>>14024600 (pb)

>>14024521 (pb)

>>14024538 (pb)

>>14024545 (pb)

>>14024557 (pb)

>>14024510 (pb)

>>14123425

not hidden.

not made widely known either.

guy who got nobel for graphene in 2010 also got Nobel iin 2001… forLevitating a FROGwith its emf 'field' and blood metal/mineral content. AND his wife is ph.d studying electromagnetic properties of graphine. both at graphine institute at Manchester University.

coincidences…

>>14123425

>>14123526

Irina Grigorieva

Andre Geim

>>14123580

>sweden

>graphene

https://www.clintonfoundation.org/contributors

>chalmers university sweden

https://news.cision.com/chalmers/r/sweden-s-quantum-computer-project-shifts-up-a-gear,c3305315

Knut and Alice Wallenberg Foundation is almost doubling the annual budget of the research initiative Wallenberg Centre for Quantum Technology, based at Chalmers University of Technology, Sweden. This will allow the centre to shift up a gear and set even higher goals – especially in its development of a quantum computer. Two international workshops will kick-start this new phase.

”Quantum technology has enormous potential and it is important that Sweden has the necessary skills in the area. During the short time since the center was founded, WACQT has built up a qualified research environment, established collaborations with Swedish industry and succeeded in developing qubits with proven problem-solving ability. We can look ahead with great confidence at what they will go on to achieve,” says Peter Wallenberg Jr, Chair Knut and Alice Wallenberg Foundation.

Since 2018, Chalmers University of Technology has been managing a large, forward-thinking research initiative – the Wallenberg Centre for Quantum Technology (WACQT) – setting Sweden on course to global prominence in quantum technology. The main project is to develop and build a quantum computer, offering far greater computing power than today's best supercomputers.

During the first three years, the quantum computer researchers within WACQT have focused first on making the basic building blocks of the quantum computer – the qubits – work as well as possible, at small scale. A milestone was reached in 2020, when they managed to solve a small part of a real-world optimisation problem with their well-functioning two-qubit quantum computer.

Increases the quality of the hundred qubits

Now comes the time to significantly scale up the number of qubits, and increase the efforts on developing software and algorithms. At the same time, the entire research initiative is being scaled up, with Knut and Alice Wallenberg Foundation (KAW) deciding to almost double WACQT's annual budget, from SEK 45 to 80 million per year for the coming four years. The investment has previously also been extended from its original ten years to twelve, and has now a total funding of at least SEK 1.3 billion including contributions from industry and the participating universities.

“It is very encouraging that KAW shows such great confidence in us. It strengthens WACQT’s research programme and gives us the opportunity to build an even better quantum computer. In terms of the number of qubits, the goal is still one hundred, but now we are aiming at one hundred really high-performance qubits,” says Per Delsing, director of WACQT and Professor at Chalmers.

Calculations have shown that the performance of the final quantum computer will benefit more from increasing the quality of the individual qubits, rather than the total number of qubits. The better their quality , the more useful the final quantum computer.

With the increased funding, WACQT will, among other things, invest in improving the materials in the superconducting chips that constitute the qubits. Quantum states are extremely sensitive, and the slightest disturbance in the materials can impair performance. The qubits manufactured at Chalmers are already among the best in the world, so improving them entails moving the entire research field into new territory.

“These disturbances are extremely small. It requires research just to understand what they are and which are most common. We need to study the entire manufacturing process in detail and explore new ways to eliminate disturbances in the material,” Delsing explains.

Will employ another 40 researchers

With the increased funding, the number of researchers working in the quantum computer project can now be significantly increased. For example, a new team will be formed to study nanophotonic devices that can enable the interconnection of several smaller quantum processors into a large quantum computer. Within the next two years, the research force will be expanded by 40 people, almost double the current amount. In a first step, fifteen new postdocs will be recruited.

>>14123729

>>14123580

>>14123548

“This is an ambitious recruitment in a highly competitive niche area. But our hopes are high – through previous recruitments we have attracted top talents both from Sweden and internationally. We have a unique interaction with the industry, extensive experience of superconducting circuits and an amazing clean room facility,” says Delsing.

To mark the quantum computer project’s new, next-level development, WACQT is organising two international workshops: one on quantum software and optimisation (8–9 April), and the second on enabling technology and algorithms for quantum computing (13–14 April). Anyone curious to hear about the state of the art in quantum computing can follow the workshops online.

“These are very exciting times in quantum computing. New steps are being taken all the time and the competition is rapidly increasing, with many countries making major investments. This investment will ensure that Sweden and Chalmers remain at the global forefront,” Delsing says.